Hypernephroma Archive - Seite 4 von 6 - IOZK

Vaccine therapy in patients with renal cell carcinoma

2009-01-30/in Hypernephroma, International Publications, IOZK Veröffentlichungen /von 2009-01-30 / Eur. Urol. 2009 Jun;55(6):1333-42

Vaccination with transforming growth factor-beta insensitive dendritic cells suppresses pulmonary metastases of renal carcinoma in mice

2008-11-28/in Hypernephroma, International Publications /von 2008-11-28 / Cancer Lett. 2008 Nov;271(2):333-41

Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial

2008-10-01/in Hypernephroma, International Publications /von 2008-10-01 / J. Immunother. 2008 Oct;31(8):771-80

Dendritic cell therapy in combination with interferon-alpha for the treatment of metastatic renal cell carcinoma

2008-06-16/in Dendritic Cells, Hypernephroma, International Publications /von 2008-06-16 / Int. J. Urol. 2008 Aug;15(8):694-8

Delivery of whole tumor lysate into dendritic cells for cancer vaccination

2008-01-01/in Dendritic Cells, Hypernephroma, International Publications, NSCLC /von 2008-01-01 / Methods Mol. Biol. 2008;423:139-53

Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma

2007-10-03/in Hypernephroma, International Publications /von 2007-10-03 / Clin. Immunol. 2007 Dec;125(3):257-67

Apoptic renal carcinoma cells are better inducers of cross-presenting activity than their primary necrotic counterpart

2007-10-01/in Hypernephroma, International Publications /von 2007-10-01 / Int J Immunopathol Pharmacol 2007 Oct-Dec;20(4):707-17

Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma

2007-10-01/in Hypernephroma, International Publications /von 2007-10-01 / J. Immunother. 2007 Oct;30(7):749-61

Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine

2007-09-01/in Hypernephroma, International Publications /von 2007-09-01 / J. Immunol. 2007 Sep;179(5):2860-9

Combined treatment of dendritoma vaccine and low-dose interleukin-2 in stage IV renal cell carcinoma patients induced clinical response: A pilot study

2007-09-01/in Hypernephroma, International Publications /von 2007-09-01 / Oncol. Rep. 2007 Sep;18(3):665-71